Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > KYMR Kymera Therapeutics > Detailed Quotes

KYMR Kymera Therapeutics

22.070
-0.660-2.90%
Close 09/29 16:00 ET
High
22.180
Open
22.180
Turnover
11.65M
Low
20.830
Pre Close
22.730
Volume
534.99K
Market Cap
1.21B
P/E(TTM)
Loss
52wk High
69.120
Shares
54.71M
P/E(Static)
Loss
52wk Low
13.150
Float Cap
807.31M
Bid/Ask %
42.86%
Historical High
91.920
Shs Float
36.58M
Volume Ratio
0.92
Historical Low
13.150
Dividend TTM
--
Div Yield TTM
--
P/B
3.03
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.46%
Amplitude
5.94%
Avg Price
21.772
Lot Size
1
Float Cap
807.31M
Bid/Ask %
42.86%
Historical High
91.920
Shs Float
36.58M
Volume Ratio
0.92
Historical Low
13.150
Dividend TTM
--
P/B
3.03
Dividend LFY
--
Turnover Ratio
1.46%
Amplitude
5.94%
Avg Price
21.772
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Kymera Therapeutics, Inc. operates as a biotechnology company, which engages in curing untreatable diseases. It focuses on discovering and developing novel small molecule therapeutics. The firm's proprietary integrated degradation platform consists of informatics-driven target identification, novel E3 ligases and ligands, proprietary predictive modeling, and novel degradation tools. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.
CEO: Dr. Nello Mainolfi, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...